Showing results (2011-2020 of 2,051) with videos related to
Sort By:
Pageof 206
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 12, 2018
Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized TrialScott E Kasner, Pablo Lavados, Mukul Sharma, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 24, 2021
Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patientsTalia L Fuchs, Fiona Maclean, John Turchini, et al.Physical Review Letters|April 4, 2020
g Factor of the ^{99}Zr (7/2^{+}) Isomer: Monopole Evolution in the Shape-Coexisting RegionF Boulay, G S Simpson, Y Ichikawa, et al.BMJ Open|July 9, 2018
Rationale and design for the detection and neurological impact of cerebrovascular events in non-cardiac surgery patients cohort evaluation (NeuroVISION) study: a prospective international cohort studyMarko Mrkobrada, Matthew T V Chan, David Cowan, et al.European Stroke Journal|April 23, 2019
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trialRobert G Hart, Mukul Sharma, Hardi Mundl, et al.The Lancet. Neurology|December 15, 2023
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trialMukul Sharma, Carlos A Molina, Kazunori Toyoda, et al.The Lancet. Oncology|November 11, 2023
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective studyQinghe Zeng, Christophe Klein, Stefano Caruso, et al.The New England Journal of Medicine|May 17, 2018
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined SourceRobert G Hart, Mukul Sharma, Hardi Mundl, et al.European Stroke Journal|January 30, 2026
Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke preventionMukul Sharma, Qiang Dong, Teruyuki Hirano, et al.The Journal of the Association of Physicians of India|June 24, 2025
Expert Consensus on Lifestyle Modifications in Hypertension Management: An Indian PerspectiveJagdish Hiremath, Gurpreet S Wander, Arup Dasbiswas, et al.Pageof 206